Back to search results

Improving Sexual and Urinary Function for Prostate Cancer Survivors

This study is testing a program called SUFICS-PACT to help prostate cancer survivors with sexual and urinary problems. SUFICS-PACT involves screening for these issues and then providing collaborative treatment. This treatment includes care managers with mental health and psychosexual counseling training, along with nurses and doctors. The study aims to see how well SUFICS-PACT identifies and treats these problems in prostate cancer survivors at NYC H+H/Bellevue. To join, you must be at least 18 years old, have been diagnosed with prostate cancer, and have sought treatment for it. The study will measure how many patients are identified and treated for sexual and urinary dysfunction over five years. The current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 200 men. It will compare a group receiving SUFICS-PACT to a control group in a randomized controlled trial.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will track the number of patients identified and treated for sexual and urinary dysfunction for five years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06637852

Sexual and Urinary Function Improvement for Cancer Survivors

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
NYU Langone Health
~200 participants
Updated 2026-07-30 on ClinicalTrials.gov
What's tested:SUFICS-PACT

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of patients identified and treated for sexual dysfunction
Measured over Year 5
+1 more outcome measured

Conditions

Urinary Dysfunction
Sexual Dysfunction

Explore related trials

Prostate CarcinomaSexual DysfunctionUrinary dysfunction

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Nnenaya A. Mmonu, MD, MS · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Who to contact

Nnenaya Mmonu, MD, MS
[email protected]
646-825-6300
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

At least 18 years old
Have a diagnosis of prostate cancer
Have sought care/treatment for prostate cancer

Exclusion

Patients under 18 years old
Patients who have not sought care/treatment for prostate cancer
Patients who are categorized as "vulnerable subjects," such as minors or incarcerated individuals.

What this trial measures

  • Number of patients identified and treated for sexual dysfunctionYear 5
  • Number of patients identified and treated for urinary dysfunctionYear 5